EPO Patents = 5

Trademarks = 5

Forward Citations = 12

Loading Chart...

9 inventors (with patents filed for the assignee):

Owe Orwar (4 out of 27 patents)

Alar Ainla (4 out of 5 patents)

Aldo Jesorka (3 out of 6 patents)

4. Gavin Jeffries (1 out of 1 patent)

5. Shijun Xu (1 out of 1 patent)

6. Gavin David Michael Jeffries (1 out of 1 patent)

7. Mehrnaz Shaali (1 patent)

8. Irep Gözen (0 patent)

9. Owe Orwar (0 patent)

10. Vladimir Kirejev (0 patent)

11. Gavin DM Jeffries (0 patent)

12. Gavin D M Jeffries (0 patent)

13. Alar Ainla (0 patent)

4 patents: Sort by Forward Citations

1. 12012578 - Cell printing utilizing recirculating fluid flows (2024-06-18),

2. 9671366 - Pipettes, methods of use, and methods of stimulating an object of interest (2017-06-06),

3. 9658240 - Microfluidic device with holding interface, and methods of use (2017-05-23),

4. 9126197 - Pipettes, methods of use, and methods of stimulating an object of interest (2015-09-08),

Company Overview

Fluicell AB is a biotechnology company that specializes in the development of innovative technologies for single cell research. Their core product, Biopixlar, is a unique single-cell dispensing system that enables highly controlled and precise manipulation of individual cells for a variety of applications in life science research and drug discovery.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#128 in Gothenburg

#1,305 in Sweden

Gothenburg, Sweden

Fluicell Ab

Forward Citations = 12

9 inventors:

Owe Orwar (4 out of 27 patents)

Alar Ainla (4 out of 5 patents)

Aldo Jesorka (3 out of 6 patents)

4. Gavin Jeffries (1 out of 1 patent)

5. Shijun Xu (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fluicell Ab. Retrieved from https://idiyas.com/company/fluicell-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]